A multi-center phase II study of nonmyeloablative conditioning with TBI [total body irradiation] and fludarabine for HLA-matched related hematopoietic cell transplantation for treatment of chronic myeloid leukemia in chronic and accelerated phase
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Fludarabine (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 17 Nov 2011 Biomarkers information updated
- 31 Aug 2007 Status change from recruiting to completed.
- 21 Nov 2005 New trial record.